Rewriting the health playbook: How Abu Dhabi is scaling AI and digital care
The 2025 theme, 'Towards Longevity: Redefining Health and Well-being,' mirrors ADGHW's ambition: shifting from episodic treatment to continuous, preventive, and personalised care.
The promise of digital health and AI
One pressing theme that has dominated the public health discourse in the past few years is digital health and artificial intelligence (AI). Advanced technologies are unlocking new frontiers by improving access, enhancing clinical outcomes, and supporting more resilient health systems. From remote monitoring, AI-diagnostics, to telemedicine and predictive analysis, Abu Dhabi is reimagining care pathways to deliver personalised treatment while empowering providers with real-time, data-driven insights.
ET Spotlight
H.E. Dr. Noura Khamis Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi
According to H.E. Dr. Noura Khamis Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi, 'Digital health allows us to tailor care to the needs of each individual while improving access across diverse communities. Whether through telemedicine platforms or data-enabled prevention strategies, our focus is on strengthening system resilience and enhancing patient outcomes.'
Abu Dhabi's growing trust-based health data and technical infrastructure presents a fertile ground for innovation. Initiatives such as Malaffi, the region's first Health Information Exchange, and the Emirati Genome Program are central to this vision. While the former facilitates real-time data sharing among care providers, the latter creates a unique dataset to analyse genetic predispositions to build better individual and population-level responses in health management.
Live Events
India's interest in scaling population health genomics (through initiatives such as the Genome India project, which aims to map the genetic diversity of the Indian population) aligns with such frameworks in Abu Dhabi. Data governance, ethical AI usage, and consent frameworks are some of the fronts where cross-border collaboration could be envisioned.
Innovation Through Strategic Initiatives
Initiatives announced at ADGHW 2025 reflect Abu Dhabi's role as a global health innovation leader, unveiling a suite of bold new initiatives that move digital health from concept to execution.
Notably, the launch of the Health, Endurance, Longevity, and Medicine (HELM) Cluster—a partnership between the Abu Dhabi Investment Office, Mohamed bin Zayed University of Artificial Intelligence, and Hub71—signals a bold step toward advancing health life sciences, R&D, and building a robust ecosystem for medical innovation, pharmaceutical manufacturing, and biotechnology.
The Startup Zone and Smart Health Hackathon spotlighted emerging innovators tackling real-world health challenges through AI-powered and digital-first approaches. The inaugural ADGHW Innovation Awards were also introduced, recognising breakthroughs that are driving meaningful improvements in patient outcomes, healthcare accessibility, and system efficiency.
A human-centred approach to innovation
However, digital transformation in healthcare transcends the technological realm. It must be rooted in the realities of patients and on-ground experiences that have emerged from years of clinical practice. Dr. Asma Al Mannaei, Executive Director of the of the Health Life Sciences Sector at the Department of Health – Abu Dhabi, underscores its impact; 'The future of health is patient-centred. Technology is a powerful enabler, but the true impact comes when innovations align with human need.'
Technologies shown at ADGHW are shifting health towards proactive and predictive models of care, helping individuals manage chronic conditions, while algorithms interpret patient data to identify health risks before they escalate.
B
uilding a future-ready healthcare workforce
The success of this transformation depends equally on human capital. As AI and digital tools become more embedded in health workflows, there is a growing need for skilled professionals who can operate in hybrid, tech-enabled environments.
'Investing in workforce development is key to realising the benefits of digital health,' notes Dr. Rashed Obaid Al Suwaidi, Director General of the Abu Dhabi Public Health Centre (ADPHC) . 'Our role is to ensure that future clinicians and allied health professionals are equipped with both clinical and digital competencies, ensuring a seamless integration of innovation into care delivery.'
This is true in the context of India as well, as it seeks to upskill its healthcare workforce to adopt emerging technologies. Abu Dhabi's initiatives present a model for India's academic and public-private institutions. The focus is on supporting the development of an AI-trained workforce capable of advancing both diagnostic precision and operational efficiency.
Public health, equity, and global collaboration
ADGHW 2025 also steered conversations on policy innovation, to drive an actionable agenda across global collaborators. A major milestone was the launch of a Global Declaration on Longevity and Precision Health, outlining an actionable agenda to extend both lifespan and healthspan through international cooperation and innovation, placing longevity at the heart of global health priorities.
The Department of Health – Abu Dhabi (DoH) also signed a landmark Memorandum of Understanding (MoU), which focuses on advancing precision medicine and genomics in oncology, rare genetic disorders, and metabolic diseases, leveraging AI and collaborative research to pioneer new treatment pathways. This multi-stakeholder partnership included PureHealth, M42, Illumina, Khalifa University (KU), New York University Abu Dhabi (NYUAD), and the Institute for Healthier Living Abu Dhabi (IHLAD).
In a world-first, Abu Dhabi unveiled the AI-powered Population Health Intelligence Framework—a learning health system designed to continuously predict, prevent, and respond to public health challenges through AI and real-time analytics.
'Public health must be inclusive, data-informed, and anticipatory,' says H.E. Dr. Rached Obaid Al Suwaidi, Director-General of Abu Dhabi Public Health Center (ADPHC). 'Through ADGHW, we are advocating for integrated approaches that connect population health strategies with emerging digital tools.'
This intersection of innovation and inclusion is critical as healthcare systems globally face challenges of scale, access, and sustainability. Through these measures, Abu Dhabi is positioning itself as both a contributor and convener in shaping the global health agenda.
Infrastructure for impact
Technology alone does not deliver transformation, it must be embedded within systems designed for agility, interoperability, and scale. Ibrahim Al Jallaf, Division Director of Digital Health at DoH, underscores that 'Our focus is on integrating digital health tools into a unified ecosystem. Whether it's through regulatory frameworks, investment incentives, or data platforms, we are building the infrastructure to support sustained impact.'
ADGHW also provides the economic foundation for this transformation. By 2045, Abu Dhabi's life sciences sector is projected to contribute over AED 94 billion to GDP and generate more than 30,000 jobs. This economic vision is tightly interlinked with the health innovation agenda, making the Emirate a compelling hub for Indian health tech startups seeking Middle East expansion.
From Abu Dhabi to the world
As a year-round platform, ADGHW fosters a strategic bridge between global health priorities and local capacity, creating a space where data, expertise, and ambition converge.
For leaders across government, academia, industry, and civil society, it presents an opportunity to co-create solutions that resonate far beyond borders, enhancing health outcomes not only for individuals but for entire communities and nations.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hindustan Times
10 minutes ago
- Hindustan Times
Built in India: Tynor and its Next Chapter in Global Orthopedic Care
With a disproportionately rising elderly population, increase in healthcare insurance, and surge in orthopedic conditions, the demand for effective, accessible, and affordable care is growing. At the same time, healthcare awareness and spending are rising. The growing demand for quality healthcare is supported by Indian government initiatives like Ayushman Bharat, making India a ripe ground for large-scale health transformation. Breaking barriers of cost and access to bring world-class healthcare within everyone's reach, Tynor has, over three decades, expanded into a comprehensive healthcare solution company. It is India's #1 doctor-recommended ortho brand, trusted across 60 countries and present in over 500,000 retail outlets and 3,000 hospitals. Tynor offers 300+ products that support consumers through every life stage, injury, surgery, sports, workouts, desk jobs, daily chores, and special life events. At its core lies a thought, that orthotics isn't just about healing, it's about enabling as well. And in a world where pain shouldn't be normalized, Tynor's mission to reduce pain, accelerate recovery, and prevent injuries feels more urgent than ever. As India will soon have a disproportionately rising elderly population, products once considered futuristic, like exoskeletons for elderly independence, will become mainstream. Tynor is ready to serve the country by addressing this challenge head-on. While these devices made in developed countries cost a fortune, Tynor aims to manufacture them in-house. With the 'China Plus One' strategy gaining ground, Tynor is strongly positioned to serve as a trusted global partner, combining scale and speed. Many global brands and retail giants are now turning to Tynor as a dependable, quality-driven resource. Its JV with Thuasne Group, France and the investment from Lighthouse PE (US) reflect this growing global trust. It is on track to become one of the top 3 global orthotic companies leading with quality and accessibility. Science and systems are at the heart of everything Tynor does, driving every product development, enhancing process robustness, and powering relentless R&D to shape the future of orthopedic care. Innovation is a way of life, with a growing pipeline of patents and design filings. Digital ortho wearables, products with Functional Electro Stimulation (FES), Transcutaneous Electro Nerve Stimulation (TENS) for pain relief, and exoskeletons are set to hit the market soon. Tynor's DNA is built on lean management—championed by Dr. P. J. Singh, Ph.D. in Lean Management—to drive continual improvement. The enterprise leverages the science of backward integration to improve supply chain control, reduce costs and enhance efficiency. Over the years, the company's Founder & CMD, Dr. Pushvinder Jit Singh's pioneering leadership has been recognised at some of the most prestigious platforms in India and abroad. From being honoured with the 'Best Entrepreneur of India' award by the Hon'ble President of India in 2010, to receiving the 'Emerging Leader – Asia Pacific' award from the Deputy Prime Minister of Thailand in 2013, his journey is one of consistent excellence. In 2014, he was felicitated as the 'Distinguished Entrepreneur of India' by the PHD Chamber, and most recently, he was conferred the 'Udyog Ratna' award by the Hon'ble President of India in 2025 — a testament to his enduring contribution to India's healthcare and manufacturing ecosystem. The company is also distinguished by key certifications that showcase its unwavering commitment to quality, safety, and compliance with standards. Tynor has adopted several manufacturing and process innovations, including the use of 20 tools of modified Toyota Production System TPS-led productivity, full Industry 4.0 compliance, a robust Tech Roadmap and Tech Matrix for optimal technology adoption, AI-enhanced camera vision for quality control and technology to boost productivity. The 'Tynor Foundation' is dedicated to empowering communities through social initiatives that focus on skill development, quality education, and effective employment generation. It fosters innovation and sustainable growth by supporting research and development, nurturing startups, and strengthening industry-academia partnerships. Moreover, the company is committed to enhancing the lives of individuals with disabilities, promoting sports as a means of unity and well-being and advocating for animal welfare. Its strong governance practices, ESG compliance mechanism, and sustainability efforts make it a future-ready enterprise with conscience. Note to readers: This article is part of HT's paid consumer connect initiative and is independently created by the brand. HT assumes no editorial responsibility for the content, including its accuracy, completeness, or any errors or omissions. Readers are advised to verify all information independently. Want to get your story featured as above? click here!
NDTV
10 minutes ago
- NDTV
Sports Fraternity Condoles The Demise Of 1972 Olympic Medallist Vece Paes
The sports fraternity has mourned the passing of Dr. Vece Paes, an Olympic medallist and father of tennis legend Leander Paes, who died on Thursday at the age of 80. A prominent midfielder from the golden era of Indian hockey, Dr. Paes was a member of the Indian team that clinched the bronze medal at the 1972 Munich Olympics. Dr. Paes, who served Indian sport with distinction both on and off the field, was suffering from an advanced stage of Parkinson's disease. He was admitted to Woodlands Hospital late on August 12 with multiorgan dysfunction due to lower respiratory tract & gastrointestinal tract infections. He had been under the Woodlands Home Care Service for the past ten months. Born in Goa in April, 1945, Dr Paes was exceptional in both sports and academics. Beyond his athletic achievements, he was also a doctor of sports medicine and served as president of the Calcutta Cricket and Football Club. Dr Paes started his medical practice at NRS Medical College and Woodlands Hospital in the 1960s. "Very saddened by the passing of former Indian player and Olympic bronze medalist Dr. Vece 'Doc' Paes. The hockey family is grateful for what he gave to our sport as a player and then as a sports physician. We extend our condolences to his family and friends, as well as Hockey India', said FIH president Tayyab Ikram. "Deeply saddened by the passing of Dr. Vece Paes, a great hockey player, Olympic medalist & true motivator for athletes like me. Father of 7-time Olympian & Atlanta 1996 bronze medalist Leander Paes. His legacy in Indian sports will live his soul rest in peace Om Shanti," said four-time Olympian Dhanraj Pillayi. Former India hockey team captain Viren Rasquinha, said, "Very sad to hear of the passing of Dr. Vece Paes. He was a midfielder with the team that won the bronze medal at 1972 Munich Olympics. An amazing Sports Physician, he was team doctor when I played at Athens 2004. Incredible human being. RIP Doc. Thank you for everything." Besides hockey, Paes showed his skills by playing divisional cricket, football, and rugby. His love for rugby led him to become the president of the Indian Rugby Football Union from 1996 to 2002. "An Olympian, seasoned sports administrator & sports medicine pioneer, he brought passion, vision & dedication to every game he touched. His legacy will forever inspire us & Indian Sports," Rugby India mourned the demise of its 1st president. In football, Dr. Paes made invaluable contributions to sports medicine in India. He was Chairman of the AIFF Medical Commission from 2003 to 2006, during which he conceptualised comprehensive sports medicine programmes, sports medicine centres, training and accreditation of sports medicine teams, and propagated the Peak Performance Programme with the national teams (seniors, U19, U17 and U15), as well as various National Football League clubs. He later served as Chairman of the AIFF Medical Committee from 2017 to 2020. Former Indian cricket team all-rounder Yusuf Pathan shared on X, "Saddened to hear about the passing of Dr. Vece Paes, father of Leander Paes and the first doctor to win medals at both the Olympics and the World Cup. A great sportsperson and a wonderful human being. My heartfelt condolences to the family."
Time of India
43 minutes ago
- Time of India
Goa becomes India's first state to cut prices on high-cost cancer and rare disease therapies
In a bid to make life-saving therapies more accessible to patients, the Goa government has introduced a groundbreaking pricing policy for expensive treatments, including those for cancer and rare diseases, according to a TOI report. Independence Day 2025 Before Trump, British used tariffs to kill Indian textile Bank of Azad Hind: When Netaji gave India its own currency Swadeshi 2.0: India is no longer just a market, it's a maker The initiative allows the state to procure drugs, medical equipment, and diagnostics at negotiated prices below the listed rates, enabling resources to reach a larger number of patients or extend the duration of therapies. Health Minister Vishwajit Rane announced on Wednesday that Goa is the first state in the country to implement such a policy framework, which facilitates confidential pricing agreements with pharmaceutical companies and medical device manufacturers. The rollout is expected to begin with treatments for lung cancer, a condition among several high-cost therapies that can exceed Rs 50 lakh per year. According to Rane, this initiative represents a significant step toward health equity, ensuring more patients can access critical care. 'Goa's adoption of this value-based pricing policy is both timely and essential,' Rane said. 'It will improve access to innovative therapies and help more patients benefit from these treatments.' Live Events Addressing the rising burden of diseases The report noted that Goa faces a growing healthcare challenge, with around 1,500 new cancer cases diagnosed annually, expected to rise by 5% each year. Breast cancer is the most common, accounting for over 300 cases, followed by oral cavity cancer, which makes up 20-25% of total cases. Rane highlighted the need for a more robust healthcare system to meet the increasing demand for specialized treatments and rare disease management. Policy framework & implementation The new pricing policy focuses on proprietary drugs and equipment already procured by the Goa Medical College (GMC) and the Directorate of Health Services (DHS) through standard tenders. If new patented drugs or devices are required, a committee will review the recommendation and seek approval from the finance department before inclusion. A committee led by the Additional/Joint Secretary of Health, along with the GMC dean, DHS director, and pharmacy heads, will determine appropriate pricing and negotiate with companies to secure the best rates for patented treatments. Once approved, the finalized list of drugs and equipment will be notified with finance department approval, TOI further reported. This move is expected to ease financial pressure on patients while equipping Goa's healthcare system to better handle the rising incidence of cancer and rare disorders, setting a precedent for other states to follow.
